Latest Medtech News
Hyalex Orthopaedics, a Lexington, Massachusetts, company, has announced the first commercial procedure with its HYALEX Slalom MTP Hemiarthroplasty Implant. Foot and ankle surgeon Dr. Jesse Doty of Integrity Orthopedics and Sports Medicine in Chattanooga, Tennessee, performed the case.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like this one. Subscribe to our Industry Insights for weekly coverage.
Hallux rigidus is the most common arthritic condition of the great toe joint and can cause pain, stiffness, reduced range of motion and limits on daily activity. First MTP joint fusion has long been considered a reliable option for advanced disease, but it gives up motion in the joint. Slalom is a motion-preserving alternative for appropriately selected patients who want to keep joint motion. The implant is built on Hyalex’s proprietary Hydrosurf material, which the company designed to replicate the biomechanical properties of native cartilage.
For Hyalex, the case follows FDA 510(k) clearance of the implant in April and marks the start of its commercial phase. Dr. Doty said he looks forward to evaluating patient outcomes as treatment options for hallux rigidus expand. CEO Carl Vause said the company intends to widen the options available to surgeons and patients who want to keep motion in the first MTP joint.
For the broader MedTech space, it adds a new synthetic-surface implant to foot and ankle surgery, where fusion has been the long-standing standard.



